Figure 2From: Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients Positive COX-2 immunostaining status is associated with shorter disease free survival time (A), shorter metastasis free survival time (B) and shorter overall survival (C) time in node-negative breast cancer patients.Back to article page